BIOMAT Database Logo BIOMAT Database Logo

New potent imidazoisoquinolinone derivatives as anti-Trypanosoma cruzi agents: biological evaluation and structure-activity relationships. 2009

Mariela Bollini, and Juan José Casal, and Diego E Alvarez, and Lucía Boiani, and Mercedes González, and Hugo Cerecetto, and Ana María Bruno
Departamento de Química Orgánica, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Junín 956, 1113 Buenos Aires, Argentina.

A series of novel benzoimidazo and N-aryl-5-oxo-imidazo[1,2-b]isoquinoline-10-carbothioamides was developed. All the compounds were evaluated for their in vitro action against the epimastigote form of Trypanosoma cruzi. Four of them showed higher activity than Nifurtimox. Their unspecific cytotoxicity was evaluated using HeLa and L6 cells, being non-toxic at concentrations at least 15 and 200 times higher than that of T. cruzi IC(50.) To gain insight into the mechanism of action, their DNA binding properties and reactivity with glutathione were studied, and QSAR study was performed.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D007546 Isoquinolines A group of compounds with the heterocyclic ring structure of benzo(c)pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. (From Stedman, 25th ed)
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005978 Glutathione A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides. Reduced Glutathione,gamma-L-Glu-L-Cys-Gly,gamma-L-Glutamyl-L-Cysteinylglycine,Glutathione, Reduced,gamma L Glu L Cys Gly,gamma L Glutamyl L Cysteinylglycine
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014344 Trypanocidal Agents Agents destructive to the protozoal organisms belonging to the suborder TRYPANOSOMATINA. Trypanocidal Drugs,Trypanocides,Trypanosomicidal Agents,Trypanosomicides,Agents, Trypanocidal,Agents, Trypanosomicidal,Drugs, Trypanocidal

Related Publications

Mariela Bollini, and Juan José Casal, and Diego E Alvarez, and Lucía Boiani, and Mercedes González, and Hugo Cerecetto, and Ana María Bruno
Imidazolidines as new anti-Trypanosoma cruzi agents: biological evaluation and structure-activity relationships.
March 2008, Bioorganic & medicinal chemistry,
Mariela Bollini, and Juan José Casal, and Diego E Alvarez, and Lucía Boiani, and Mercedes González, and Hugo Cerecetto, and Ana María Bruno
New imidazolidine derivatives as anti-Trypanosoma cruzi agents: structure-activity relationships.
December 2012, Parasitology research,
Mariela Bollini, and Juan José Casal, and Diego E Alvarez, and Lucía Boiani, and Mercedes González, and Hugo Cerecetto, and Ana María Bruno
Synthesis, biological evaluation, and structure-activity relationships of potent noncovalent and nonpeptidic cruzain inhibitors as anti-Trypanosoma cruzi agents.
March 2014, Journal of medicinal chemistry,
Mariela Bollini, and Juan José Casal, and Diego E Alvarez, and Lucía Boiani, and Mercedes González, and Hugo Cerecetto, and Ana María Bruno
Synthesis and biological evaluation of new sulfonamide derivatives as potential anti-Trypanosoma cruzi agents.
November 2012, Medicinal chemistry (Shariqah (United Arab Emirates)),
Mariela Bollini, and Juan José Casal, and Diego E Alvarez, and Lucía Boiani, and Mercedes González, and Hugo Cerecetto, and Ana María Bruno
Ruthenium complexes endowed with potent anti-Trypanosoma cruzi activity: Synthesis, biological characterization and structure-activity relationships.
July 2009, Bioorganic & medicinal chemistry,
Mariela Bollini, and Juan José Casal, and Diego E Alvarez, and Lucía Boiani, and Mercedes González, and Hugo Cerecetto, and Ana María Bruno
Synthesis, biological evaluation and structure-activity relationships of new quinoxaline derivatives as anti-Plasmodium falciparum agents.
February 2014, Molecules (Basel, Switzerland),
Mariela Bollini, and Juan José Casal, and Diego E Alvarez, and Lucía Boiani, and Mercedes González, and Hugo Cerecetto, and Ana María Bruno
Indirubin derivatives are potent and selective anti-Trypanosoma cruzi agents.
January 2018, Virulence,
Mariela Bollini, and Juan José Casal, and Diego E Alvarez, and Lucía Boiani, and Mercedes González, and Hugo Cerecetto, and Ana María Bruno
Structure-activity relationships of novel N-imidazoylpiperazines with potent anti-Trypanosoma cruzi activity.
January 2024, Future medicinal chemistry,
Mariela Bollini, and Juan José Casal, and Diego E Alvarez, and Lucía Boiani, and Mercedes González, and Hugo Cerecetto, and Ana María Bruno
Second generation of 5-ethenylbenzofuroxan derivatives as inhibitors of Trypanosoma cruzi growth: synthesis, biological evaluation, and structure-activity relationships.
April 2007, Bioorganic & medicinal chemistry,
Mariela Bollini, and Juan José Casal, and Diego E Alvarez, and Lucía Boiani, and Mercedes González, and Hugo Cerecetto, and Ana María Bruno
Identification of novel benzimidazole derivatives as anti-Trypanosoma cruzi agents: solid-phase synthesis, structure-activity relationships and molecular docking studies.
October 2013, Future medicinal chemistry,
Copied contents to your clipboard!